Noul Co.,Ltd.
Research Noul Co.,Ltd. (376930.KQ) on Bullrun: market cap KRW 14.68B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker376930.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyKRW
- Market capKRW 14.68B
- Financial periodQ2 2026
- RevenueKRW 1.01B
- Net income-KRW 4.69B
- Free cash flow-KRW 3.85B
- Gross margin19.8%
Valuation Snapshot
latest market cap is KRW 14.68B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 14.68B | n/a | n/a | n/a |
Dividend history
About Noul Co.,Ltd.
Noul Co.,Ltd. engages in the in-vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, immunohistochemistry services, and digital cervical cell analysis solution. Noul Co.,Ltd. was incorporated in 2015 and is headquartered in Yongin-si, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Noul Co.,Ltd.'s market cap?
Noul Co.,Ltd.'s market capitalization is KRW 14.68B.
What does Noul Co.,Ltd. do?
Noul Co.,Ltd. engages in the in-vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, immunohistochemistry services, and digital cervical cell analysis solution. Noul Co.,Ltd. was incorporated in 2015 and is headquartered in Yongin-si, South Korea.